We are live on ! Find out more
NFA

Nationwide Fund Advisors Portfolio holdings

AUM $2.42B
1-Year Est. Return 17.68%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+17.68%
3 Year Est. Return
+28.25%
5 Year Est. Return
+4.07%
10 Year Est. Return
+82.68%
AUM
$24.1B
AUM Growth
+$131M
Cap. Flow
-$801M
Cap. Flow %
-3.33%
Top 10 Hldgs %
10.07%
Holding
3,288
New
60
Increased
781
Reduced
1,861
Closed
92

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$35.1M
2
KEY icon
KeyCorp
KEY
+$28.3M
3
ALLY icon
Ally Financial
ALLY
+$20M
4
UNP icon
Union Pacific
UNP
+$20M
5
EW icon
Edwards Lifesciences
EW
+$17.8M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$31.8M
2
LOW icon
Lowe's Companies
LOW
+$31.6M
3
WFC icon
Wells Fargo
WFC
+$30.7M
4
V icon
Visa
V
+$23.3M
5
SHW icon
Sherwin-Williams
SHW
+$21.6M

Sector Composition

Rank Sector Weight
1 Technology 16.04%
2 Financials 15.7%
3 Healthcare 13.02%
4 Industrials 12.38%
5 Consumer Discretionary 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOGO
3026
DELISTED
Fogo de Chao, Inc. Common Stock
FOGO
$43K ﹤0.01%
3,002
GSOL
3027
DELISTED
Global Sources Ltd
GSOL
$43K ﹤0.01%
4,913
INFI
3028
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$42K ﹤0.01%
31,080
CRDF icon
3029
Cardiff Oncology
CRDF
$66.5M
$41K ﹤0.01%
272
RVSB icon
3030
Riverview Bancorp
RVSB
$107M
$41K ﹤0.01%
5,811
LPCN icon
3031
Lipocine
LPCN
$17.5M
$39K ﹤0.01%
619
ABCD
3032
DELISTED
Cambium Learning Group, Inc.
ABCD
$39K ﹤0.01%
7,885
APVO icon
3033
Aptevo Therapeutics
APVO
$5.12M
0
MIND icon
3034
MIND Technology
MIND
$45.3M
$37K ﹤0.01%
894
+80
+10% +$2.85K
VHI icon
3035
Valhi
VHI
$380M
$37K ﹤0.01%
900
AXTI icon
3036
AXT Inc
AXTI
$3.95B
$36K ﹤0.01%
7,515
LWAY icon
3037
Lifeway Foods
LWAY
$455M
$36K ﹤0.01%
3,170
OESX icon
3038
Orion Energy Systems
OESX
$41M
$36K ﹤0.01%
1,656
TOVX icon
3039
Theriva Biologics
TOVX
$9.64M
$36K ﹤0.01%
5
AGFS
3040
DELISTED
AgroFresh Solutions Inc
AGFS
$36K ﹤0.01%
13,434
HMTV
3041
DELISTED
Hemisphere Media Group, Inc.
HMTV
$36K ﹤0.01%
3,176
-1,166
-27% -$13.8K
VSLR
3042
DELISTED
VIVINT SOLAR, INC.
VSLR
$36K ﹤0.01%
14,165
DSCI
3043
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$36K ﹤0.01%
6,892
-21,716
-76% -$102K
MRUS
3044
DELISTED
Merus
MRUS
$35K ﹤0.01%
+1,670
New +$28.5K
DCOY
3045
Decoy Therapeutics
DCOY
$2.19M
0
DALN
3046
DELISTED
DallasNews
DALN
$34K ﹤0.01%
1,322
GCBC icon
3047
Greene County Bancorp
GCBC
$570M
$34K ﹤0.01%
2,952
MRTX
3048
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$34K ﹤0.01%
7,245
USAP
3049
DELISTED
Universal Stainless & Alloy
USAP
$33K ﹤0.01%
2,462
ATTO
3050
DELISTED
Atento S.A.
ATTO
$33K ﹤0.01%
+853
New +$35.7K

Similar funds

Nationwide Fund Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Nationwide Fund Advisors held 3,288 positions worth $24.1B, up 0.55% from $23.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Nationwide Fund Advisors withdrew a net $801M in Q4 2016, closing 92 positions and reducing 1,861 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $19.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Nationwide Fund Advisors opened a new position in Lamb Weston worth $15.1M.

  • Nationwide Fund Advisors's largest Q4 2016 buy was Lamb Weston: 399,561 shares worth $15.1M.
  • Nationwide Fund Advisors added most to Mastercard in Q4 2016, an estimated $35.1M increase.
  • Nationwide Fund Advisors's biggest Q4 2016 reduction was JPMorgan Chase, cutting an estimated $31.8M.
  • Nationwide Fund Advisors fully exited Terminix Global Holdings, Inc. in Q4 2016, selling an estimated $19.6M.
  • Nationwide Fund Advisors's ten largest holdings make up 10% of its $24.1B portfolio in Q4 2016.
  • Nationwide Fund Advisors opened 60 new positions and closed 92 in Q4 2016.
  • Nationwide Fund Advisors's portfolio value rose 0.55% quarter-over-quarter to $24.1B.

Based on Nationwide Fund Advisors's 13F filing for Q4 2016, filed 27 Jan 2017.